Jasper Therapeutics, Inc.
JSPR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.
Other share classesJSPRW
Q4 2024 vs. Q3 2024
How the institutions holding Jasper Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 81 | 88 | +7 |
| Shares | 14.7M | 15.7M | +969.5K (+6.6%) |
| Value | $274.8M | $334.5M | +$59.8M (+21.8%) |
New holders (21)
Institutions that held Jasper Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boxer Capital Management, LLC | 350,000 | $7.48M | 0.64% |
| StemPoint Capital LP | 135,244 | $2.89M | 0.73% |
| T. Rowe Price Investment Management, Inc. | 82,165 | $1.76M | 0.00% |
| Schroder Investment Management Group | 59,034 | $1.24M | 0.00% |
| Jefferies Financial Group Inc. | 31,250 | $668.1K | 0.01% |
| Palo Alto Investors LP | 30,651 | $655.3K | 0.10% |
| Sowell Financial Services LLC | 28,043 | $599.6K | 0.03% |
| Allostery Investments LP | 22,000 | $470.4K | 0.92% |
| Simplify Asset Management Inc. | 20,000 | $427.6K | 0.03% |
| Propel Bio Management, LLC | 20,000 | $427.6K | 0.42% |
| State of Wisconsin Investment Board | 13,724 | $293.4K | 0.00% |
| Tema ETFs LLC | 12,435 | $265.9K | 0.11% |
| EntryPoint Capital, LLC | 10,431 | $223.0K | 0.09% |
| Police & Firemen's Retirement System of New Jersey | 2,276 | $48.7K | 0.00% |
| Creative Planning | 1,032 | $22.1K | 0.00% |
| R Squared Ltd | 720 | $15.4K | 0.01% |
| Group One Trading, L.P. | 500 | $10.7K | 0.00% |
| Greenline Partners, LLC | 100 | $2.14K | 0.00% |
| GAMMA Investing LLC | 16 | $342 | 0.00% |
| SBI Securities Co., Ltd. | 6 | $128 | 0.00% |
| IFP Advisors, Inc | 0 | $21 | 0.00% |
Sold out (14)
Institutions that held Jasper Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Polar Capital Holdings Plc | 581,538 | $10.9M |
| Boxer Capital, LLC | 350,000 | $6.58M |
| AlphaCentric Advisors LLC | 17,500 | $329.2K |
| ADAR1 Capital Management, LLC | 15,816 | $297.5K |
| Balyasny Asset Management LLC | 14,743 | $277.3K |
| NEOS Investment Management LLC | 11,219 | $211.0K |
| Shay Capital LLC | 10,000 | $188.1K |
| LMR Partners LLP | 5,274 | $99.2K |
| STRS Ohio | 2,100 | $39.5K |
| Simplex Trading, LLC | 1,354 | $25.0K |
| Acadian Asset Management LLC | 930 | $17.0K |
| Signaturefd, LLC | 11 | $207 |
| Danske Bank A/S | 2 | $38 |
| National Bank of Canada | 1 | $19 |